NeuroFlow Acquires 2nd Behavioral Health Company in 1 Year
Behavioral health companies are consolidating to meet the rising demand for mental…
Asian gastro docs generally trust and accept AI: survey
A recent international study conducted by Nanyang Technological University Singapore looked at…
CGM metrics predict risk for stage 3 type 1 diabetes better than patient characteristics
Continuous glucose monitoring (CGM) metrics can predict imminent stage 3 type 1…
Kaiser’s Risant Health to add Cone Health
Kaiser Permanente announced the acquisition of Cone Health in North Carolina, expanding…
Growth factors linked to stem cell aging in bone marrow study
A study conducted at the Jackson Laboratory focused on hematopoietic stem cells…
New study warns of potential pandemic risk from α-H1N2 swine flu virus
A recent study in Nature Communications focused on circulating swine influenza viruses,…
Fixed-Ratio Insulin Combinations May Reduce Side Effects
Using fixed-ratio insulin combinations (FRC) can reduce side effects in treating diabetes,…
Roche Adds Another Neuro Alliance, Inking R&D Pact With RNA-Editing Startup Ascidian
Roche has partnered with Ascidian Therapeutics, a startup focused on editing RNA…
Annexon previews emerging data on ANX007 for geographic atrophy
Lori Taylor of Annexon Biosciences presented data on ANX007 for the treatment…
With type 2 diabetes, ‘we’re failing right now,’ FDA chief says
FDA Commissioner Robert Califf highlighted the concerning trend of deteriorating health outcomes…